Home : DrugWatch : Inspra : News Articles

Inspra - News Articles

Polskie Towarzystwo Kardiologiczne


Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med, 2011; 364: 11–21|17.01.2011 W przeprowadzonych przed kilku laty badaniach klinicznych RALES (Randomized Aldactone Evaluation Study) i EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) ...
RCM Pharma - Marketing Farmacêutico - Actualidade


doentes num ensaio de fase final que está a testar o seu medicamento Inspra® (eplerenone) como tratamento para a insuficiência cardíaca após aqueles que tomaram o fármaco terem registado uma redução "significativa" do risco de morte cardiovascular e hospitalização por insuficiência cardíaca, em ...
UroToday - Please Login - Abiraterone acetate: A promising drug for the treatment of castration-resistant prostate cancer - Abstract


These include hypertension, hypokalemia and edema and are easily manageable with a selective mineralocorticoid antagonist, such as eplerenone, ...
A Comparison of Outcomes in Patients in New York Heart Association Class II Heart Failure When Treated With Eplerenone or Placebo in Addition to Standard Heart Failure Medicines (EMPHASIS-HF)


The goal of the trial was to evaluate treatment with eplerenone compared to placebo among patients with mild to moderate heart failure that are at risk of sudden death. ...
Biggest Large Cap Movers (PFE, MON, NOK) | Penny Stock Live


The company said it's halted recruitment to its Phase III trial of Inspra in addition to current standard of care in reducing the risk of cardiovascular death or heart failure due to the significant benefit observed. Monsanto Company (NYSE:MON) went down ...
Morning Read: What do May venture dollar flurries bring? « MedCity News


It's a good thing: Pfizer (NYSE: PFE) is to halt recruitment of patients to the EMPHASIS-HF trial testing Inspra for mild heart-failure patients because of ...
The Day - Pfizer heart drug might be next big thing | News from southeastern Connecticut


In the past two weeks, Pfizer also has announced successes with its hypertension treatment Inspra and lung-cancer drug crizotinib, though none of the drugs was discovered in Groton, where Pfizer has its largest research site worldwide. But the news on apixaban ...
Pfizer's Beating Heart - Forbes.com


Its drug, Inspra, had already been shown to reduce the risk of cardiovascular death or heart failure hospitalization when used in conjunction with the current standard of care. Article Controls email print ...
INSPRA? – COST EFFECTIVE WHEN ADDED TO CURRENT STANDARD CARE FOR POST-MYOCARDIAL INFARCTION HEART FAILURE, SAYS YORK HTA REPORT - News Press Release | PharmiWeb.com


London, UK, 3rd June 2010 – Health economists say Inspra (eplerenone) is cost-effective when added to usual care, compared to usual care alone in the management of heart failure (HF) following a myocardial infarction (MI).[1] The researchers from the University of York, ...
Want to contact an Inspra attorney in District of Columbia?...Get a free case evaluation from one of our Inspra attorneys in District of Columbia now.

Need An Inspra Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Want to contact an Inspra attorney in District of Columbia?...Get a free case evaluation from one of our Inspra attorneys in District of Columbia now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Inspra Case - Submit Your Information Below

Do you need legal assistance with your Inspra case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Inspra Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.
This form is secure and encrypted. More information about secure forms and your privacy here.